A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).
Clinical trial NCT01734993 · COMPLETED
Trial details
- NCT number
- NCT01734993
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2015-09-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.